SAS Output

10-APR-2021 6:10

LYMPH ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1608-FL, TGR-1202/Lenalidomide/CHOP or Benda +Ob 1 Y 1 TGR-1202 + Obinutuzumab 150 22 5 2 0 0 0 01/23/2018 205 83
        2 Lenalidomide + Obinutuzumab   19 5 1 1 0 0      
        3 CHOP + Obinutuzumab   9 2 0 0 0 0      
        4 Bendamustine + Obinutuzumab   10 4 2 2 1 1      
            60 16 5 3 1 1      
 
  S1826-HD, Adv, Age 12+, N+AVD vs BV+AVD 1 Y 1 Nivolumab + AVD 987 203 158 92 56 18 3 08/29/2019 291 142
        2 Brentuximab Vedotin + AVD   202 156 90 54 18 1      
            405 314 182 110 36 4      
 
Yes A051301-ABC DLBCL, Auto HCT and Ibrutinib/Placebo 0 E Total Registrations   65 8 6 2 1 0 10/12/2016 156 66
            65 8 6 2 1 0      
 
    1 E Total Registrations   12 5 4 1 0 0 10/12/2016    
            12 5 4 1 0 0      
 
  E4412-HD, RR, Ipilimumab +Nivo +Brentuximab Vedotin 1 E Total Registrations   19 12 9 6 1 0 04/17/2019 143 66
            19 12 9 6 1 0      
 
  EA4151-Lymph, AHCT +/-Ritux, MRD Neg 0 E Total Registrations   81 30 19 11 4 0 04/03/2018 148 74
            81 30 19 11 4 0      
 
    1 E Total Registrations   59 22 13 8 6 3 04/03/2018    
            59 22 13 8 6 3      
 
  EA4181-MCL, Randomization BR/CR v BR/CR-A v BR-A 1 E Total Registrations   30 26 17 9 2 0 12/13/2019 170 72
            30 26 17 9 2 0      
 
No A051701-LYMPH, MYC/BC2 DHL&DEL, R-chemo+/-Venetoclax 1 T Total Registrations   33 24 8 2 1 0 01/02/2020 212 98
            33 24 8 2 1 0      
 
  E4402-NHL, Low Tumor, Compare Rituximab Dosing 1 E Total Registrations   5 0 0 0 0 0 11/09/2004    
            5 0 0 0 0 0      
 

10-APR-2021 6:10

LYMPH Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date # of
ACT.
INSTs
# of
CURR
IRBs
S1918 DLBCL, Adv, Age 75+, CC-486 +/- R-miniCHOP 1 Randomization 19-Mar-21 4 1